20 January 2014 in The EMBO Journal
Pathogenic bacteria introduce effector proteins directly into the cytosol of eukaryotic cells to promote invasion and colonization. OspG, a Shigella spp. effector kinase, plays a role in this process by helping to suppress the host inflammatory response. OspG has been reported to bind host E2 ubiquitin‐conjugating enzymes activated with ubiquitin (E2~Ub), a key enzyme complex in ubiquitin transfer pathways. A co‐crystal structure of the OspG/UbcH5c~Ub complex reveals that complex formation has important ramifications for the activity of both OspG and the UbcH5c~Ub conjugate. OspG is a minimal kinase domain containing only essential elements required for catalysis. UbcH5c~Ub binding stabilizes an active conformation of the kinase, greatly enhancing OspG kinase activity. In contrast, interaction with OspG stabilizes an extended, less reactive form of UbcH5c~Ub. Recognizing conserved E2 features, OspG can interact with at least ten distinct human E2s~Ub. Mouse oral infection studies indicate that E2~Ub conjugates act as novel regulators of OspG effector kinase function in eukaryotic host cells. See also: [MF de Jong & NM Alto][1] (January 2014) ![][2] The crystal structure of a complex between ubiquitin‐loaded UbcH5c and the Shigella effector kinase OspG shows how they regulate each other, and has allowed to demonstrate the role of this interaction in repressing host innate immune responses. EMBO Journal (2014) 33, 437–449 [1]: http://dx.doi.org/10.1002/embj.201387606 [2]: pending:yes
12 June 2023 in The EMBO Journal
26 March 2022 in Trends in Biochemical Sciences
1 January 2019 in Journal of Biological Chemistry
SspH/IpaH bacterial effector E3 ubiquitin ligases, unrelated in sequence or structure to eukaryotic E3s, are utilized by a wide variety of gram-negative bacteria during pathogenesis. These E3s function in a eukaryotic environment, utilize host cell E2 ubiquitin-conjugating enzymes of the Ube2D family, and target host proteins for ubiquitylation. Despite several crystal structures, details of Ube2D~Ub binding and the mechanism of ubiquitin transfer are poorly understood. Here we show that the catalytic E3 ligase domain of SspH1 can be divided into two subdomains; an N-terminal subdomain that harbors the active site cysteine, and a C-terminal subdomain containing the Ube2D~Ub binding site. SspH1 mutations designed to restrict subdomain motions show rapid formation of an E3~Ub intermediate, but impaired Ub transfer to substrate. NMR experiments using paramagnetic spin labels reveal how SspH1 binds Ube2D~Ub and targets the E2~Ub active site. Unexpectedly, hydrogen/deuterium exchange mass spectrometry shows that the E2~Ub binding region is dynamic but stabilized in the E3~Ub intermediate. Our results support a model in which both subunits of an Ube2D~Ub clamp onto a dynamic region of SspH1 promoting an E3 conformation poised for transthiolation. A conformational change is then required for Ub transfer from E3~Ub to substrate.